Figure 2From: Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events: results of a long-term follow-up study in routine clinical care Kaplan-Meier Estimates of Secondary Fatal and Non-Fatal CVD Events During Follow-Up (time=days) According to CYP2C19C*2 Allele Status in Patients with no Intake of Clopidogrel or Ticopidine at Baseline and One Year Follow-up). Back to article page